ロード中...

The novel CXCR4 antagonist POL5551 mobilizes hematopoietic stem and progenitor cells with greater efficiency than Plerixafor

Mobilized blood has supplanted bone marrow (BM) as the primary source of hematopoietic stem cells for autologous and allogeneic stem cell transplantation. Pharmacologically enforced egress of hematopoietic stem cells from BM, or mobilization, has been achieved by directly or indirectly targeting the...

詳細記述

保存先:
書誌詳細
主要な著者: Karpova, D, Dauber, K, Spohn, G, Chudziak, D, Wiercinska, E, Schulz, M, Pettit, A R, Levesque, J P, Romagnoli, B, Patel, K, Chevalier, E, Dembowsky, K, Bonig, H
フォーマット: Artigo
言語:Inglês
出版事項: Nature Publishing Group 2013
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC3865534/
https://ncbi.nlm.nih.gov/pubmed/24072044
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/leu.2013.266
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!